Promega corporation:1107424 [16-002867]ADP-GLO(TM) kinase assay, 100,000 assays, kinase-GLO(R) plus luminescent kinase assay 10 X 100ML, and ADP-GLO(TM) kinase assay, 10,000 assays for matthew hall…
Ended Awarded
- Contract number
- HHSN31900010
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,260
Award facts
- Contract value 100% obligated
- $21,260.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation received a contract award valued at $21,260 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, on April 12, 2016. This firm fixed-price BPA (Blanket Purchase Agreement) call was issued without small business set-aside designation and required performance in Madison, Wisconsin, with completion by February 28, 2017. The contract procures specialized kinase assay products including ADP-Glo Kinase Assay kits (100,000 assays and 10,000 assays) and Kinase-Glo Plus Luminescent Kinase Assay reagents (10 x 100mL) for named researchers Matthew Hall and Mindy Davis.
This award represents a task order against Promega's existing $10 million NIH BPA for biological materials, chemicals, and scientific equipment. The kinase assay products support translational research activities at NCATS, which focuses on improving the efficiency of biomedical research and facilitating the development of diagnostics and therapeutics. Promega, a large life sciences manufacturer headquartered in Madison, specializes in biological research and diagnostic products and maintains an established track record supplying advanced scientific instruments and reagents to federal research agencies including NIH, CDC, and the FBI.
Description
Promega corporation:1107424 [16-002867]ADP-GLO(TM) kinase assay, 100,000 assays, kinase-GLO(R) plus luminescent kinase assay 10 X 100ML, and ADP-GLO(TM) kinase assay, 10,000 assays for matthew hall and mindy davis.
Quick answers
Who was awarded contract HHSN31900010?
HHSN31900010 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on April 12, 2016.
How much is contract HHSN31900010 worth?
The government has obligated $21,260 on HHSN31900010.
Is contract HHSN31900010 an order under another contract?
Yes. HHSN31900010 is a BPA call under HHSN263201500038B, a blanket purchase agreement.
Was contract HHSN31900010 competed?
The extent of competition for HHSN31900010 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award